Home » Newsletters » BioWorld Asia

BioWorld Asia

June 21, 2000

View Archived Issues

Qiagen Acquiring Operon In Stock Deal Valued At $110M

EU Ministers Take Steps To Promote European Research

French Oppose Commission Directive On Biotech Patents

NsGene, Biogen Collaborate In Neublastin Deal Worth $20M

Kirkman Seeks Greater Role For BIA As He Assumes Top Position

Recap Of Deals, Financings Now Available From BioWorld

GPC Biotech, Karo Collaborate To Identify Novel Antibiotics

Commissioner Says Industry Brought GMO Flap On Itself

OECD Report To G8 Calls For Harmonization Of Regulations

Lorantis Completing First Round To Fund Program Around Notch

QBI Plans IPO As Biotech In Israel Gets Venture Boost

Other News To Note

Bioniche Identifies New Class Of Molecules Against Cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.